| MeSH term | MeSH ID | Detail |
|---|---|---|
| Inflammation | D007249 | 119 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Tibial Fractures | D013978 | 4 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
| Carotid Artery Thrombosis | D002341 | 7 associated lipids |
| Coronary Artery Disease | D003324 | 47 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Alcoholic Intoxication | D000435 | 15 associated lipids |
| Ascites | D001201 | 25 associated lipids |
| Down Syndrome | D004314 | 18 associated lipids |
| Bartter Syndrome | D001477 | 5 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Catella-Lawson F et al. | Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. | 1999 | J. Pharmacol. Exp. Ther. | pmid:10215647 |
| Morrow JD et al. | Increased formation of thromboxane in vivo in humans with mastocytosis. | 1999 | J. Invest. Dermatol. | pmid:10417625 |
| Mills JL et al. | Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. | 1999 | JAMA | pmid:10432033 |
| Barden AE et al. | Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? | 1999 | J. Hypertens. | pmid:10489109 |
| Mizugaki M et al. | Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593167 |
| Hishinuma T et al. | Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593168 |
| Hoch B and Bernhard M | Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593170 |
| Arvola P et al. | Exercise enhances vasorelaxation in experimental obesity associated hypertension. | 1999 | Cardiovasc. Res. | pmid:10615427 |
| Tanaka H et al. | Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients? | 1999 | Respir Med | pmid:10653051 |
| Numminen H et al. | The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. | 2000 | Stroke | pmid:10835443 |
| Tsikas D et al. | Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine. | 2000 | J Chromatogr A | pmid:10941682 |
| Belton O et al. | Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. | 2000 | Circulation | pmid:10952950 |
| Delemarre FM et al. | Urinary prostaglandin excretion in pregnancy: the effect of dietary sodium restriction. | 2000 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:11049696 |
| Brown NJ et al. | Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. | 2000 | Circulation | pmid:11056091 |
| Praticò D et al. | Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11248083 |
| Dowd NP et al. | Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo. | 2001 | J. Clin. Invest. | pmid:11518732 |
| Kaaja R et al. | Increased thromboxane production in women with a history of venous thromboembolic event: effect of heparins. | 2001 | Br. J. Haematol. | pmid:11552994 |
| Hishinuma T et al. | Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. | 2001 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:11728171 |
| Stichtenoth DO et al. | Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease. | 2001 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:11728174 |
| Saareks V et al. | Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. | 2002 | Pharmacol. Toxicol. | pmid:12403056 |
| Sinzinger H | Comments on "Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications". | 2002 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12445490 |
| Kudolo GB et al. | Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. | 2002 | Thromb. Res. | pmid:12590952 |
| Wennmalm A et al. | 2,3-Dinor metabolites of thromboxane A2 and prostacyclin in urine from healthy human subjects: diurnal variation and relation to 24h excretion. | 1992 | Clin. Sci. | pmid:1330409 |
| Wennmalm A | Formation of prostacyclin during administration of beta 1-selective and non-selective beta-adrenergic antagonists in healthy humans. | 1992 | Clin Physiol | pmid:1347260 |
| Martrat A et al. | Altered systemic and tissue prostacyclin in cerulein induced acute pancreatitis in rats. | 1992 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:1384068 |
| Larsson PT et al. | Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation. | 1992 | Eur. J. Clin. Pharmacol. | pmid:1387607 |
| Tohgi H et al. | Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. | 1992 | Stroke | pmid:1412574 |
| RÃ¥ngemark C et al. | Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. | 1992 | Circulation | pmid:1423963 |
| Capone ML et al. | Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. | 2004 | Circulation | pmid:15037526 |
| Mastrogiannis DS et al. | Cocaine decreases urinary prostacyclin release in pregnancy: correlation with uterine and umbilical Doppler velocimetry. | 2003 | J. Matern. Fetal. Neonatal. Med. | pmid:15061316 |
| Hashimoto K et al. | Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness. | 2004 | J. Virol. | pmid:15367596 |
| Vainio M et al. | Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. | 2004 | Acta Obstet Gynecol Scand | pmid:15548142 |
| Saloheimo P et al. | Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. | 2005 | Thromb. Res. | pmid:15733969 |
| Christman BW et al. | An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. | 1992 | N. Engl. J. Med. | pmid:1603138 |
| Stichtenoth DO et al. | Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. | 2005 | Kidney Int. | pmid:16221219 |
| Lin JS et al. | The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence. | 1992 | J. Urol. | pmid:1635125 |
| RÃ¥ngemark C and Wennmalm A | Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. | 1991 | Clin. Sci. | pmid:1649717 |
| Tulppala M et al. | Thromboxane dominance and prostacyclin deficiency in habitual abortion. | 1991 | Lancet | pmid:1672969 |
| Stergioulas AT and Filippou DK | Effects of physical conditioning on lipids and arachidonic acid metabolites in untrained boys: a longitudinal study. | 2006 | Appl Physiol Nutr Metab | pmid:16900233 |
| Guarner C et al. | Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination. | 1992 | Gastroenterology | pmid:1727763 |
| Kurki T et al. | Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin. | 1992 | Am. J. Obstet. Gynecol. | pmid:1733190 |
| Capone ML et al. | Human pharmacology of naproxen sodium. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17473175 |
| Neulen J et al. | Arachidonic acid metabolism and prostaglandin production by primate preimplantation blastocysts. | 1991 | Prostaglandins | pmid:1775634 |
| Arnaud J et al. | Effect of low dose antioxidant vitamin and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites. | 2007 | J Am Coll Nutr | pmid:17914127 |
| Schwartz JI et al. | Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. | 2007 | J Clin Pharmacol | pmid:17925592 |
| Aitokallio-Tallberg AM et al. | Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma. | 1991 | Cancer Res. | pmid:1868436 |
| Signore C et al. | Markers of oxidative stress and systemic vasoconstriction in pregnant women drinking > or =48 g of alcohol per day. | 2008 | Alcohol. Clin. Exp. Res. | pmid:18715278 |
| Presser SC et al. | Simultaneous measurements of prostacyclin and thromboxane metabolites during the menstrual cycle. | 1991 | Am. J. Obstet. Gynecol. | pmid:1892191 |
| Foudi N et al. | Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. | 2009 | Cardiovasc. Res. | pmid:18952694 |
| Zhao L et al. | Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor. | 2009 | Br. J. Pharmacol. | pmid:19220291 |
| Ward PS et al. | Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1. | 1991 | Br. J. Pharmacol. | pmid:1933130 |
| Greer IA et al. | Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation. | 1990 May-Jun | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:1970789 |
| Foudi N et al. | Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits. | 2009 | Am. J. Physiol. Heart Circ. Physiol. | pmid:19783781 |
| Rasmanis G et al. | Prostacyclin production in myocardial infarction in the acute phase and during follow-up. | 1991 | J. Intern. Med. | pmid:1997639 |
| Wennmalm A et al. | Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. | 1991 | Circulation | pmid:2022025 |
| Blatnik M and Steenwyk RC | Quantification of urinary PGEm, 6-keto PGF(1alpha) and 2,3-dinor-6-keto PGF(1alpha) by UFLC-MS/MS before and after exercise. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20416393 |
| Vernon WB | Prostaglandins and pancreas transplantation. | 1991 | Prostaglandins | pmid:2052737 |
| Hotter G et al. | Altered levels of tissue and urinary prostacyclin in rats subjected to pancreas transplantation. | 1991 | Prostaglandins | pmid:2052738 |
| Fukushima H et al. | Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin. | 2010 | Am. J. Med. Genet. A | pmid:20583254 |
| Yuhki K et al. | [Prostaglandin I2 and its metabolites]. | 2010 | Nippon Rinsho | pmid:20960743 |
| Ylikorkala O et al. | Urinary excretion of prostacyclin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy. | 1990 | Prostaglandins | pmid:2106714 |
| Henriksson P et al. | Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo. | 1990 | Prostaglandins | pmid:2106716 |
| Edlund A et al. | Acipimox stimulates skin blood flow by a cyclo-oxygenase-dependent mechanism. | 1990 | Eur. J. Clin. Pharmacol. | pmid:2125938 |
| Piret A et al. | Increased platelet aggregability and prostacyclin biosynthesis induced by intense physical exercise. | 1990 | Thromb. Res. | pmid:2140206 |
| Lynch CM et al. | The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. | 2011 | Prostaglandins Other Lipid Mediat. | pmid:21723954 |
| Wennmalm A et al. | Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors. | 1990 | Clin. Sci. | pmid:2176952 |
| Skarke C et al. | Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. | 2012 | Clin. Pharmacol. Ther. | pmid:22278334 |
| Song WL et al. | Niacin and biosynthesis of PGDâ‚‚by platelet COX-1 in mice and humans. | 2012 | J. Clin. Invest. | pmid:22406532 |
| pmid:24671522 | ||||
| Ross S et al. | Association of cyclooxygenase-2 genetic variant with cardiovascular disease. | 2014 | Eur. Heart J. | pmid:24796340 |
| Hamazaki T et al. | Urinary excretion of PGI2/3-M and recent N-6/3 fatty acid intake. | 1989 | Prostaglandins | pmid:2503856 |
| Ruth V et al. | Urinary excretion of prostacyclin metabolites in infants born after maternal preeclampsia or with birth asphyxia. | 1989 | Biol. Neonate | pmid:2506939 |
| Koivisto VA et al. | Stimulation of prostacyclin synthesis by physical exercise in type I diabetes. | 1989 | Diabetes Care | pmid:2507264 |
| Lupinetti MD et al. | Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. | 1989 | Am. Rev. Respir. Dis. | pmid:2508524 |
| Vesterqvist O and Gréen K | Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man. | 1989 | Eur. J. Clin. Pharmacol. | pmid:2515064 |
| Beckmann ML et al. | Prostacyclin synthesis is increased during propranolol therapy for essential hypertension. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526468 |
| Knapp HR and Salem N | Formation of PGI3 in the rat during dietary fish oil supplementation. | 1989 | Prostaglandins | pmid:2557651 |
| pmid:25669623 | ||||
| Ritter JM et al. | Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. | 1989 | Br J Clin Pharmacol | pmid:2590611 |
| Chiabrando C et al. | Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. | 1989 | J. Chromatogr. | pmid:2613794 |
| Förstermann U et al. | An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A. | 1989 | Prostaglandins | pmid:2662262 |
| Grèen K et al. | Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). | 1989 | Prostaglandins | pmid:2664901 |
| Rousson D et al. | Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura. | 1989 | Br. J. Haematol. | pmid:2669929 |
| Kühl PG et al. | Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension. | 1989 | Arch. Dis. Child. | pmid:2673060 |
| Barrow SE et al. | Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. | 1989 | Biochim. Biophys. Acta | pmid:2679889 |
| pmid:27137142 | ||||
| Aitokallio-Tallberg A et al. | Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment. | 1989 | Br. J. Cancer | pmid:2803956 |
| Gréen K et al. | Deficient prostacyclin formation after acute myocardial infarction. | 1987 | Lancet | pmid:2883378 |
| Edlund A et al. | Myocardial ischaemia triggers formation of thromboxane. | 1987 | Lancet | pmid:2887865 |
| Fischer C and Meese CO | Simultaneous determination of 6-oxo-prostaglandin F1 alpha and 2,3-dinor-6-oxo-prostaglandin F1 alpha in biological fluids by stable isotope dilution and negative ion chemical ionization mass spectrometry. | 1985 | Biomed. Mass Spectrom. | pmid:2931130 |
| Reilly IA et al. | Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. | 1986 | Circulation | pmid:2938849 |
| Gréen K and Vesterqvist O | In vivo synthesis of thromboxane and prostacyclin in man in health and disease. Data from GC-MS measurements of major urinary metabolites. | 1986 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2949557 |
| Gréen K and Vesterqvist O | In vivo synthesis of thromboxane A2 and prostaglandin I2 in healthy and diseased individuals. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959096 |
| Edlund A et al. | Leg exercise increases prostacyclin synthesis without activating platelets in both healthy and atherosclerotic humans. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959097 |
| Ciabattoni G et al. | Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960163 |
| Castagnoli MN et al. | Combined high-performance liquid chromatography and enzyme immunoassay for the determination of urinary metabolites of thromboxane and 6-keto-PGF1 alpha. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960164 |
| Ylikorkala O et al. | Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. | 1987 | J. Clin. Endocrinol. Metab. | pmid:2960690 |
| Knapp HR et al. | In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. | 1986 | N. Engl. J. Med. | pmid:3007982 |
| Balazy M et al. | Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. | 1988 | Prostaglandins | pmid:3070630 |